6-aminonicotinamide has been researched along with Brain Inflammation in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrasco, J; Hidalgo, J; Penkowa, M; Poulsen, C | 1 |
| Carrasco, J; Giralt, M; Hidalgo, J; Molinero, A; Penkowa, M; Quintana, A | 1 |
| Hidalgo, J; Penkowa, M | 1 |
| Kiktenko, AI | 1 |
1 review(s) available for 6-aminonicotinamide and Brain Inflammation
| Article | Year |
|---|---|
[Scanning electron microscopy in studies of the nervous system (review)].
Topics: 6-Aminonicotinamide; Animals; Astrocytoma; Brain Neoplasms; Cats; Cerebral Ventricles; Choroid Plexus; Cricetinae; Culture Techniques; Dementia; Encephalitis; Ependyma; Estrus; Female; Humans; Hydrocephalus; Male; Microscopy, Electron, Scanning; Microvilli; Nervous System; Pregnancy; Rabbits; Rats; Retina; Virus Diseases | 1985 |
3 other study(ies) available for 6-aminonicotinamide and Brain Inflammation
| Article | Year |
|---|---|
M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment.
Topics: 6-Aminonicotinamide; Animals; Antioxidants; Apoptosis; Astrocytes; Brain Stem; Caspases; Encephalitis; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Homozygote; In Situ Nick-End Labeling; Lymphocytes; Macrophage Colony-Stimulating Factor; Macrophages; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Microglia; Niacin; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress | 2002 |
Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Topics: 6-Aminonicotinamide; Animals; Apoptosis; Brain Stem; Caspase 3; Caspases; Crosses, Genetic; Disease Models, Animal; Down-Regulation; Encephalitis; Free Radicals; Glial Fibrillary Acidic Protein; Gliosis; Interleukin-6; Metallothionein; Mice; Mice, Transgenic; Nerve Degeneration; Neurofibrillary Tangles; Neuroglia; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Promoter Regions, Genetic | 2004 |
IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment.
Topics: 6-Aminonicotinamide; Animals; Antigens, Differentiation; Astrocytes; Blood-Brain Barrier; Bone Marrow Cells; Brain Stem; Encephalitis; Glial Fibrillary Acidic Protein; Hematopoiesis; Immunohistochemistry; Interleukin-6; Macrophages; Malondialdehyde; Metallothionein; Metallothionein 3; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Nerve Tissue Proteins; Oxidative Stress; Protein Isoforms; Serum Albumin; T-Lymphocytes; Tyrosine | 2000 |